VeriMomtranexamoyl dipeptide-22 est-il sûr pendant la grossesse ?
No harmonised CLP classification or SCCS/CIR reproductive restrictions were identified for tranexamoyl dipeptide‑22. Systemic tranexamic acid (the parent) has been used in pregnancy (e.g., treatment of hemorrhage) without teratogenic signal in clinical literature (peer‑reviewed trials), and there are no animal or human data indicating reproductive hazard from the cosmetic dipeptide derivative; therefore default hazard and mechanism scores are 0 and exposure from topical use is considered negligible for adults.
Pregnancy-safe products containing tranexamoyl dipeptide-22
Related ingredients
Frequently asked questions
- tranexamoyl dipeptide-22 est-il sûr pendant la grossesse ?
- No harmonised CLP classification or SCCS/CIR reproductive restrictions were identified for tranexamoyl dipeptide‑22. Systemic tranexamic acid (the parent) has been used in pregnancy (e.g., treatment of hemorrhage) without teratogenic signal in clinical literature (peer‑reviewed trials), and there are no animal or human data indicating reproductive hazard from the cosmetic dipeptide derivative; therefore default hazard and mechanism scores are 0 and exposure from topical use is considered negligible for adults.
- tranexamoyl dipeptide-22 est-il sûr pendant l'allaitement ?
- No data indicate reproductive or lactation-specific hazards for the ingredient or its parent in the cosmetic context. Systemic use of tranexamic acid has not been linked to teratogenicity; topical cosmetic exposures are expected to be negligible, so breastfeeding risk is not indicated.
- tranexamoyl dipeptide-22 est-il sûr pour la peau de bébé ?
- No infant‑specific hazards identified. Adult topical absorption is expected to be negligible; however, because infant skin has higher surface‑area‑to‑weight and an immature barrier, exposure score is conservatively increased by +1 (to 1) for 0–3 yr skin despite no evidence of harm or known reproductive mechanism.
- Comment VeriMom évalue-t-il tranexamoyl dipeptide-22 ?
- VeriMom évalue tranexamoyl dipeptide-22 à 100/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à tranexamoyl dipeptide-22 pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à tranexamoyl dipeptide-22 basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.